Clinical Trial Update: Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluated the combination of enzalutamide and metformin hydrochloride in patients with hormone-resistant prostate cancer; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Glucophage (metformin)
• Xtandi (enzalutamide)

Snippet

Sponsor: University of California, Davis | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED